Private equity firms Blackstone and TPG have reportedly revived their interest in acquiring medical device maker Hologic. This renewed attention follows a previous $16 billion non-binding offer that Hologic had rejected.
The rekindled interest suggests that the firms may be re-evaluating terms or market conditions for a potential deal. Hologic is a significant player in the medical technology sector, making it an attractive target for large-scale private equity investment.
While this is still in the 'interest' phase, it indicates a potential for a major acquisition in the healthcare industry. The outcome of these renewed discussions will determine if Blackstone proceeds with a formal bid.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.